TOP STORIES
haematology
Blood cancers

Early intervention with daratumumab may head off myeloma


Daratumumab monotherapy may be useful in patients with intermediate-risk or high-risk smouldering multiple myeloma (SMM) to delay their progression to MM. A phase 2 study of the monoclonal antibody in 123 patients from 47 sites worldwide...

Daratumumab monotherapy may be useful in patients with intermediate-risk or high-risk smouldering multiple myeloma (SMM) to delay their...

Read more